Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories

US pharmaceutical giant Eli Lilly announced Wednesday that it will build four additional new manufacturing sites in the United States in a committment designed to influence upcoming Trump administration decisions on trade and other issues…

About Author

Jeanice Antes

See author's posts

Eyeing Trump trade policy shakeup, Eli Lilly to build 4 US factories

About Author

Jeanice Antes

Top 10 Richest Pharmaceutical Entrepreneurs in Africa

Job titles of the future: Pharmaceutical-grade mushroom grower

Health camp by Maoists busted near Odisha-Chhattisgarh border; eye-testing equipment seized

Critical illness is more common than expected in African hospitals, but low-cost treatments offer hope

Fat transport deficiency explains rare childhood metabolic crises

Discovery of lung-based blood stem cells may transform transplant therapies

Innate immune training aggravates inflammatory bone loss in experimental models

How air pollution and wildfire smoke may contribute to memory loss in Alzheimer’s disease

GLP-1 Agents and Suicide: Making Sense of 2024’s Mixed Data

Cocktail Recall Update As FDA Issues Risk Warning for 25 States

Integrating MRD in Myeloma: Guidance for Therapy Escalation and De-escalation

CMS Moved to Expand Obesity Drug Coverage. Private Insurers Need to Step Up.

Nigeria targets 15% pharmaceutical market share in Africa by 2030 – Health Minister

Critical illness is more common than expected in African hospitals, but low-cost treatments offer hope

Fat transport deficiency explains rare childhood metabolic crises

Discovery of lung-based blood stem cells may transform transplant therapies

Innate immune training aggravates inflammatory bone loss in experimental models

How air pollution and wildfire smoke may contribute to memory loss in Alzheimer’s disease

About PhaMed

Recent News

About Author

More Stories

You may have missed

About PhaMed

Recent News

Categories